Latest Medivation Inc News and Updates
Company & Industry Overviews
How Xtandi Fueled Big Pharmaceutical Interest in MedivationXtandi is the major factor behind Pfizer’s (PFE) interest in Medivation (MDVN). The drug, along with MDVN’s pipeline molecules, should strengthen Pfizer’s (PFE) oncology franchise.
Regeneron’s Dupilumab: How Much Potential Does It Hold?Dupilumab has a breakthrough therapy designation from the FDA for the indication of moderate-to-severe atopic dermatitis in adults.